Current classification criteria of breast cancer are mainly based on hormone receptor and immunohistochemistry, while our findings open the possibility to predict disease progression with the transcriptome profile, gene set score, and cellular composition of certain cancer cell clusters. Here, NR4A1 is linked to breast cancer.